$1.97
-0.21-9.63%
At close: -
$1.98
0.010.51%
After Hours: 7:11 PM EDT
Comments
Loading...
Editas Medicine Insider Trading Activity | NASDAQ:EDIT | Benzinga
Track the latest Editas Medicine insider trading activity. Stay informed on recent buys, sells, and market impact for Editas Medicine stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Editas Medicine Inc Insiders Doing?
At Editas Medicine Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 16.36K shares worth $28.22K, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On June 4, 2025, Amy Parison, the company's SVP, CHIEF FINANCIAL OFFICER sold 446 shares for $1.72 each.
- On June 4, 2025, Linda Burkly, the company's EVP, CHIEF SCIENTIFIC OFFICER sold 726 shares for $1.72 each.
- On June 4, 2025, Neil Gilmore ONeill, the company's CEO sold 15.19K shares for $1.72 each.
Ownership Statistics for Editas Medicine Inc
Shares Outstanding
83.713M
Insider Shares Owned
2.984M
Insider Percentage Owned
3.56%
Institutional Shares Held
26.174M
Institutional Percentage Held
31.3%
| Jun 04, 2025 | Amy Parison | SVP, CHIEF FINANCIAL OFFICER | -446.00 | $1.72 | -$768.90 | SELL | -2.48% | 17.51K | Jun 03 | View |
| Jun 04, 2025 | Linda Burkly | EVP, CHIEF SCIENTIFIC OFFICER | -726.00 | $1.72 | -$1.25K | SELL | -1.03% | 69.52K | Jun 03 | View |
| Jun 04, 2025 | Neil Gilmore ONeill | CEO | -15.19K | $1.72 | -$26.20K | SELL | -5.14% | 280.28K | Jun 03 | View |
| Mar 05, 2025 | Erick Lucera | EVP, CHIEF FINANCIAL OFFICER | -4.11K | $1.71 | -$7.03K | SELL | -3.52% | 112.72K | Mar 04 | View |
| Mar 05, 2025 | Neil Gilmore ONeill | CEO | -16.63K | $1.71 | -$28.45K | SELL | -5.33% | 295.47K | Mar 04 | View |
| Mar 05, 2025 | Linda Burkly | EVP, CHIEF SCIENTIFIC OFFICER | -2.89K | $1.71 | -$4.95K | SELL | -3.95% | 70.25K | Mar 04 | View |
| Dec 05, 2024 | Neil Gilmore ONeill | CEO | -1.62K | $2.08 | -$3.36K | SELL | -0.52% | 312.11K | Dec 03 | View |
| Dec 05, 2024 | Baisong Mei | EVP, CHIEF MEDICAL OFFICER | -541.00 | $2.08 | -$1.12K | SELL | -0.40% | 133.35K | Dec 03 | View |
| Sep 06, 2024 | Baisong Mei | EVP, CHIEF MEDICAL OFFICER | -518.00 | $3.42 | -$1.77K | SELL | -0.39% | 133.90K | Sep 04 | View |
| Sep 06, 2024 | Neil Gilmore ONeill | CEO | -1.55K | $3.42 | -$5.33K | SELL | -0.49% | 313.72K | Sep 04 | View |
| Jul 26, 2024 | Linda Burkly | EVP, CHIEF SCIENTIFIC OFFICER | -11.89K | $5.42 | -$64.37K | SELL | -13.98% | 73.14K | Jul 25 | View |
| Jul 22, 2024 | Baisong Mei | EVP, CHIEF MEDICAL OFFICER | -6.62K | $5.21 | -$34.46K | SELL | -4.69% | 134.41K | Jul 19 | View |
| Jun 06, 2024 | Neil Gilmore ONeill | CEO | -12.19K | $5.50 | -$67.00K | SELL | -3.72% | 315.28K | Jun 04 | View |
| Jun 06, 2024 | Baisong Mei | EVP, CHIEF MEDICAL OFFICER | -511.00 | $5.50 | -$2.81K | SELL | -0.36% | 141.03K | Jun 04 | View |
| May 22, 2024 | Erick Lucera | EVP, CHIEF FINANCIAL OFFICER | -22.34K | $5.61 | -$125.40K | SELL | -16.05% | 116.83K | May 20 | View |
| May 14, 2024 | Jessica Hopfield | DIRECTOR | 45.00K | $5.64 | $253.87K | BUY | 198.24% | 67.70K | May 13 | View |
| Mar 05, 2024 | Neil Gilmore ONeill | CEO | 197.30K | $9.42 | -$732.88K | GRANT | 151.57% | 327.47K | Mar 02 - Mar 05 | View |
| Mar 05, 2024 | Baisong Mei | SVP, CHIEF MEDICAL OFFICER | 69.49K | $9.42 | -$191.43K | GRANT | 96.44% | 141.54K | Mar 02 - Mar 04 | View |
| Dec 07, 2023 | Bruce Eaton | EVP, CBO AND CTO | -103.00 | $10.90 | -$1.12K | SELL | -0.14% | 74.79K | Dec 05 | View |
| Nov 16, 2023 | Bruce Eaton | EVP, CBO AND CTO | -695.00 | $8.21 | -$5.71K | SELL | -0.92% | 74.89K | Nov 14 | View |
| Nov 09, 2023 | Bruce Eaton | EVP, CBO AND CTO | -139.00 | $8.40 | -$1.17K | SELL | -0.18% | 75.59K | Nov 07 | View |
| Sep 07, 2023 | Bruce Eaton | EVP, CBO AND CTO | -103.00 | $8.82 | -$908.46 | SELL | -0.14% | 75.73K | Sep 06 | View |
| Aug 15, 2023 | Bruce Eaton | EVP, CBO AND CTO | -702.00 | $8.59 | -$6.03K | SELL | -0.92% | 75.83K | Aug 11 | View |
| Aug 10, 2023 | Bruce Eaton | EVP, CBO AND CTO | -141.00 | $8.39 | -$1.18K | SELL | -0.18% | 76.53K | Aug 08 | View |
| Jul 21, 2023 | Baisong Mei | SVP, CHIEF MEDICAL OFFICER | -4.32K | $8.80 | -$37.99K | SELL | -5.65% | 72.06K | Jul 19 | View |
| Jun 07, 2023 | Neil Gilmore ONeill | CEO | -6.49K | $9.50 | -$61.64K | SELL | -4.75% | 130.17K | Jun 05 | View |
| Jun 07, 2023 | Bruce Eaton | EVP, CBO AND CTO | -105.00 | $9.50 | -$997.82 | SELL | -0.14% | 76.67K | Jun 05 | View |
| May 15, 2023 | Michelle Robertson | EVP, CHIEF FINANCIAL OFFICER | -949.00 | $9.87 | -$9.37K | SELL | -0.88% | 106.61K | May 11 | View |
| May 15, 2023 | Bruce Eaton | EVP, CBO AND CTO | -668.00 | $9.87 | -$6.59K | SELL | -0.86% | 76.78K | May 11 | View |
| May 11, 2023 | Bruce Eaton | EVP, CBO AND CTO | -135.00 | $9.51 | -$1.28K | SELL | -0.17% | 77.45K | May 09 | View |
| Mar 06, 2023 | Michelle Robertson | EVP, CHIEF FINANCIAL OFFICER | 31.32K | $8.89 | -$1.64K | GRANT | 41.07% | 107.56K | Mar 02 - Mar 03 | View |
| Mar 06, 2023 | Bruce Eaton | EVP, CBO AND CTO | 16.60K | $8.89 | -$897.89 | GRANT | 27.22% | 77.58K | Mar 02 - Mar 03 | View |
| Feb 15, 2023 | Mark Shearman | EVP, CHIEF SCIENTIFIC OFFICER | -2.79K | $9.67 | -$26.97K | SELL | -4.08% | 65.56K | Feb 13 | View |
| Feb 15, 2023 | Michelle Robertston | EVP, CHIEF FINANCIAL OFFICER | -4.29K | $9.67 | -$41.44K | SELL | -5.32% | 76.24K | Feb 13 | View |
| Feb 15, 2023 | Bruce Eaton | EVP, CBO AND CTO | -3.31K | $9.67 | -$31.96K | SELL | -5.14% | 60.98K | Feb 13 | View |
| Feb 09, 2023 | Bruce Eaton | EVP, CBO AND CTO | -346.00 | $11.10 | -$3.84K | SELL | -0.54% | 64.29K | Feb 07 | View |
| Jan 12, 2023 | Michelle Robertson | EVP, CHIEF FINANCIAL OFFICER | -1.75K | $8.16 | -$14.30K | SELL | -2.13% | 80.53K | Jan 10 | View |
| Dec 06, 2022 | Michelle Robertson | EVP, CHIEF FINANCIAL OFFICER | -193.00 | $10.23 | -$1.97K | SELL | -0.23% | 82.28K | Dec 05 | View |
| Dec 06, 2022 | Bruce Eaton | EVP, CHIEF BUSINESS OFFICER | -102.00 | $10.23 | -$1.04K | SELL | -0.16% | 64.64K | Dec 05 | View |
| Nov 09, 2022 | Bruce Eaton | EVP, CHIEF BUSINESS OFFICER | -289.00 | $11.02 | -$3.18K | SELL | -0.44% | 64.74K | Nov 08 | View |
| Sep 08, 2022 | Michelle Robertson | EVP, CHIEF FINANCIAL OFFICER | -192.00 | $15.01 | -$2.88K | SELL | -0.23% | 82.47K | Sep 06 | View |
| Sep 08, 2022 | Bruce Eaton | EVP, CHIEF BUSINESS OFFICER | -101.00 | $15.01 | -$1.52K | SELL | -0.16% | 65.03K | Sep 06 | View |
| Aug 10, 2022 | Bruce Eaton | EVP, CHIEF BUSINESS OFFICER | -293.00 | $18.60 | -$5.45K | SELL | -0.45% | 65.13K | Aug 09 | View |
| Jun 16, 2022 | Mark S Shearman | EVP, CHIEF SCIENTIFIC OFFICER | -5.14K | $10.06 | -$51.74K | SELL | -7.00% | 68.35K | Jun 15 | View |
| Jun 06, 2022 | Bruce Eaton | EVP, CHIEF BUSINESS OFFICER | -1.12K | $11.54 | -$12.96K | SELL | -1.69% | 65.42K | Jun 03 | View |
| Jun 06, 2022 | Michelle Robertson | EVP, CHIEF FINANCIAL OFFICER | -1.53K | $11.54 | -$17.62K | SELL | -1.81% | 82.67K | Jun 03 | View |
| May 11, 2022 | Bruce Eaton | EVP, CHIEF BUSINESS OFFICER | -297.00 | $13.11 | -$3.89K | SELL | -0.44% | 66.54K | May 09 | View |
| Apr 04, 2022 | Bruce Eaton | EVP, CHIEF BUSINESS OFFICER | -1.54K | $26.61 | -$41.12K | SELL | -2.26% | 66.84K | Aug 09 - Apr 01 | View |
| Mar 07, 2022 | Bruce Eaton | EVP, CHIEF BUSINESS OFFICER | -403.00 | $17.33 | -$6.98K | SELL | -0.59% | 68.39K | Mar 03 | View |
| Mar 07, 2022 | Michelle Robertson | EVP, CHIEF FINANCIAL OFFICER | -767.00 | $17.33 | -$13.29K | SELL | -0.90% | 84.19K | Mar 03 | View |
| Feb 10, 2022 | Bruce Eaton | EVP, CHIEF BUSINESS OFFICER | -302.00 | $17.63 | -$5.32K | SELL | -0.96% | 31.20K | Feb 08 | View |
| Jan 13, 2022 | Michelle Robertson | CHIEF FINANCIAL OFFICER | -1.74K | $25.70 | -$44.82K | SELL | -5.25% | 31.46K | Jan 11 | View |
| Jan 04, 2022 | James C Mullen | CEO | -18.25K | $26.95 | -$491.98K | SELL | -19.39% | 75.90K | Jan 03 | View |
| Nov 15, 2021 | Lisa Michaels | EVP/CHIEF MEDICAL OFFICER | -1.57K | $38.33 | -$60.10K | SELL | -7.84% | 18.43K | Nov 12 | View |
| Nov 10, 2021 | Bruce Eaton | EVP, CHIEF BUSINESS OFFICER | -287.00 | $40.61 | -$11.66K | SELL | -1.01% | 28.03K | Nov 09 | View |
| Oct 20, 2021 | James C Mullen | CEO | -13.80K | $38.03 | -$525.03K | SELL | -19.31% | 57.67K | Oct 18 | View |
| Aug 10, 2021 | Michelle Robertson | CHIEF FINANCIAL OFFICER | 0.00 | $45.33 | -$73.38K | SELL-OPTIONS | 0.00% | 28.73K | Aug 09 | View |
| Jun 30, 2021 | Michelle Robertson | CHIEF FINANCIAL OFFICER | 0.00 | $40.33 | -$48.38K | SELL-OPTIONS | 0.00% | 28.73K | Jun 28 | View |
| Mar 05, 2021 | Jessica Hopfield | DIRECTOR | 5.80K | $45.51 | $263.97K | BUY | 34.32% | 22.70K | Mar 03 | View |
| Mar 04, 2021 | James C Mullen | CEO | 25.00K | $46.27 | $1.16M | BUY | 250.00% | 35.00K | Mar 02 | View |
| Feb 10, 2021 | Cynthia Collins | CEO | -1.26K | $66.65 | -$84.11K | SELL | -2.80% | 43.76K | Feb 09 | View |
| Jan 13, 2021 | Michelle Robertson | CHIEF FINANCIAL OFFICER | -1.57K | $78.27 | -$122.73K | SELL | -7.84% | 18.43K | Jan 12 | View |
| Dec 17, 2020 | Charles Albright | — | 0.00 | $39.86 | -$467.06K | OPTION EXERCISE | 0.00% | 24.91K | Dec 15 | View |
| Dec 11, 2020 | Charles Albright | — | 0.00 | $30.76 | -$284.90K | OPTION EXERCISE | 0.00% | 24.91K | Dec 09 | View |
| Dec 08, 2020 | Charles Albright | — | 0.00 | $28.27 | -$470.20K | OPTION EXERCISE | 0.00% | 24.91K | Dec 07 | View |
| Nov 10, 2020 | Charles Albright | — | -228.00 | $31.21 | -$7.12K | SELL | -0.91% | 24.91K | Nov 09 | View |
| Oct 16, 2020 | Charles Albright | — | -3.00K | $31.39 | -$94.17K | SELL | -10.66% | 25.14K | Oct 15 | View |
| Aug 21, 2020 | Cynthia Collins | — | -1.98K | $36.66 | -$72.44K | SELL | -4.20% | 45.02K | Aug 20 | View |
| Aug 19, 2020 | Charles Albright | — | 0.00 | $25.90 | -$187.80K | OPTION EXERCISE | 0.00% | 28.14K | Aug 17 | View |
| Aug 10, 2020 | Charles Albright | — | -238.00 | $26.96 | -$217.93K | OPTION EXERCISE | -0.84% | 28.14K | Aug 06 - Aug 07 | View |
| Jul 17, 2020 | Charles Albright | — | -3.00K | $32.22 | -$96.66K | SELL | -9.56% | 28.37K | Jul 15 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
